End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
118,000 KRW | +0.85% | +3.24% | -5.98% |
07-03 | GC Biopharma Teams Up with US Pharmacy Benefit Manager for Immunodeficiency Treatment | MT |
06-10 | FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.98% | 976M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- A006280 Stock
- News GC Biopharma Corp.
- GC Biopharma Teams Up with US Pharmacy Benefit Manager for Immunodeficiency Treatment